TZ Ref No.: TZ-1023888
Contract Award
Awarded Contract
🌍 International (ICB)
Czechia
Pharmaceuticals
Healthcare and Medicine
Chemicals
Antineoplastics and immunomodulators 2026-II Imunosupresivum content of the active substance ublituximab
Doc ref no.
00622732-2026
Sector
Pharmaceuticals, Healthcare and Medicine, Chemicals
Contract Date
11 Sep 2026
Contract Value
Undisclosed
Contract Intelligence
AI opportunity notes and scope analysis for this contract award
Opportunity Notes
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Antineoplastics and immunomodulators 2026-II Imunosupresivum content of the active substance ublituximab
The contents of the ampoule are 150 mg ublituximabu, predpokládaný roční objem 50 ampulí (dávek); ATC L04AG14
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals